Lexeo Therapeutics, Inc. - Common stock, par value $0.0001 (LXEO)
CUSIP: 52886X107
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common stock, par value $0.0001
- Shares outstanding
- 73,698,416
- Total 13F shares
- 29,735,114
- Share change
- +1,722,736
- Total reported value
- $268,784,046
- Price per share
- $9.04
- Number of holders
- 67
- Value change
- +$10,322,355
- Number of buys
- 48
- Number of sells
- 13
Quarterly Holders Quick Answers
What is CUSIP 52886X107?
CUSIP 52886X107 identifies LXEO - Lexeo Therapeutics, Inc. - Common stock, par value $0.0001 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 52886X107:
Top shareholders of LXEO - Lexeo Therapeutics, Inc. - Common stock, par value $0.0001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
4.6%
|
3,369,147
|
$54,041,118 | — | 30 Jun 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
4.3%
|
3,163,992
|
$50,726,379 | — | 30 Jun 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
3.5%
|
2,597,736
|
$41,667,685 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3.5%
|
2,558,611
|
$41,040,120 | — | 30 Jun 2024 | |
| D1 Capital Partners L.P. |
13F
|
Company |
3.4%
|
2,506,607
|
$40,205,976 | — | 30 Jun 2024 | |
| Omega Fund Management, LLC |
13F
|
Company |
3.2%
|
2,355,904
|
$37,788,700 | — | 30 Jun 2024 | |
| Longitude Capital Partners IV, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,567,100
|
$33,933,468 | — | 07 Nov 2023 | |
| Omega Fund VI, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,157,623
|
$28,520,755 | — | 07 Nov 2023 | |
| Invest A/s Lundbeckfond |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,835,959
|
$24,268,808 | — | 07 Nov 2023 | |
| Novo Holdings A/S |
13F
|
Company |
2%
|
1,450,500
|
$23,266,020 | — | 30 Jun 2024 | |
| BRAIDWELL LP |
13F
|
Company |
1.9%
|
1,382,481
|
$22,174,995 | — | 30 Jun 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
1.1%
|
840,000
|
$13,473,600 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.1%
|
824,074
|
$13,218,147 | — | 30 Jun 2024 | |
| Blackstone Inc. |
13F
|
Company |
1.1%
|
805,757
|
$12,924,342 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.1%
|
791,584
|
$12,697,008 | — | 30 Jun 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.91%
|
672,712
|
$10,790,300 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.85%
|
629,919
|
$10,103,900 | — | 30 Jun 2024 | |
| Artal Group S.A. |
13F
|
Company |
0.82%
|
603,435
|
$9,679,097 | — | 30 Jun 2024 | |
| Laurion Capital Management LP |
13F
|
Company |
0.62%
|
453,582
|
$7,275,455 | — | 30 Jun 2024 | |
| Verition Fund Management LLC |
13F
|
Company |
0.57%
|
421,392
|
$6,759,128 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.4%
|
296,612
|
$4,758,158 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.27%
|
196,272
|
$3,148,203 | — | 30 Jun 2024 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.18%
|
132,187
|
$2,120,279 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.13%
|
94,907
|
$1,522,308 | — | 30 Jun 2024 | |
| Polar Asset Management Partners Inc. |
13F
|
Company |
0.09%
|
65,300
|
$1,047,412 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.05%
|
37,466
|
$600,955 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
31,806
|
$510,168 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.04%
|
30,861
|
$495,010 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.04%
|
26,853
|
$430,722 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.04%
|
26,759
|
$429,214 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.03%
|
22,101
|
$354,500 | — | 30 Jun 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.03%
|
19,153
|
$307,215 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.02%
|
18,293
|
$293,420 | — | 30 Jun 2024 | |
| CAXTON CORP |
13F
|
Company |
0.02%
|
17,851
|
$286,331 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
14,651
|
$235,003 | — | 30 Jun 2024 | |
| Paul McCormac |
3/4/5
|
Chief Technical Officer |
—
class O/S missing
|
17,349
|
$229,329 | — | 07 Nov 2023 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.02%
|
14,035
|
$225,121 | — | 30 Jun 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
13,357
|
$214,238 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
12,663
|
$203,114 | — | 30 Jun 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.02%
|
11,545
|
$185,182 | — | 30 Jun 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.01%
|
10,750
|
$172,430 | — | 30 Jun 2024 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.01%
|
6,420
|
$102,977 | — | 30 Jun 2024 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.01%
|
5,507
|
$88,332 | — | 30 Jun 2024 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.01%
|
4,881
|
$78,291 | — | 30 Jun 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
4,560
|
$73,142 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
4,363
|
$69,983 | — | 30 Jun 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
4,187
|
$67,159 | — | 30 Jun 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
3,341
|
$53,590 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
3,129
|
$50,189 | — | 30 Jun 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
1,950
|
$31,278 | — | 30 Jun 2024 |
Institutional Holders of Lexeo Therapeutics, Inc. - Common stock, par value $0.0001 (LXEO) as of Q3 2024
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.